Skip to main navigation Skip to search Skip to main content

Suppression of virus burden by immunization with feline immunodeficiency virus Env protein

  • Margaret J. Hosie
  • , Thomas H. Dunsford
  • , Anthony de Ronde
  • , Brian J. Willett
  • , Celia A. Cannon
  • , James C. Neil
  • , Oswald Jarrett
  • University of Glasgow
  • Amsterdam UMC - University of Amsterdam

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Whole inactivated virus (WIV) vaccines derived from the FL4 cell line protect cats against challenge with feline immunodeficiency virus (FIV). To discover whether the protective effects of WIV could be reproduced by the isolated Env component, either WIV or immunoaffinity-purified FIV gp120 from the FL4 cell line was administered to cats. Although both vaccines induced high levels of virus neutralizing antibodies, purified Env was much less effective than WIV in protecting cats against viraemia. However, reduced virus load in PBMCs was evident in all Env-immunized cats compared to controls. Analyses of antibody responses to bacterial expression products of FIV EnV, which were high in Env-immunized cats but low in animals receiving the WIV vaccine, suggested that the partially denatured, monomeric Env induces a less effective antiviral immune response than HIV. Hence, the superior immunogenicity, of WIV may be due to the presentation of the native oligomeric structure of Env on virions.
Original languageEnglish
Pages (from-to)405-411
JournalVaccine
Volume14
Issue number5
DOIs
Publication statusPublished - 1996
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Suppression of virus burden by immunization with feline immunodeficiency virus Env protein'. Together they form a unique fingerprint.

Cite this